View Document Preview and Link Document Date: 2010-04-06 17:05:36 Open Document File Size: 179,81 KB Share Result on Facebook
City Mount Prospect / New Orleans / / Company Aventis / Chiron Corporation / GlaxoSmithKline / HHS / ISMP / / Country Mexico / United States / United Kingdom / / Currency USD / / / Event FDA Phase / / Facility German GSK facility / The Sheraton New Orleans Hotel / Liverpool facility / / / IndustryTerm legitimate manufacturer / reviewed extensive manufacturing / pharmaceutical manufacturers / Web access / computer order entry systems / counterfeit product / authentic product / / MedicalCondition hypoglycemia / Alzheimer’s disease / Diabetes / severe hypoglycemia / injuries / / MedicalTreatment medication errors / emergency contraception / / Organization US Department of Health and Human Services / Food and Drug Administration / FDA’s Anti-Counterfeiting Task Force / FDA Center for Devices and Radiological Health / Institute for Safe Medication Practices / Centers for Disease Control and Prevention / FDA’s Division of Medication Errors and Technical Support / Medicines and Healthcare products Regulatory Agency / / Person Tommy G.Thompson / Session / / / Position President / Pharmacist / Secretary / producer / / Product Safe Medication / carisoprodol / simvastatin / glimepiride / Viagra / USP-ISMP Medication / AMARYL / Zocor / Fluarix® / / ProvinceOrState Illinois / Indiana / Louisiana / California / / Technology html / / URL www.ismp.org / www.fda.gov / www.accessdata.fda.gov/scripts / www.pfizer.com / www.nabp.net / www.fda.gov/cder/consumerinfo/counterfeit_all_resources.htm / www.ismp.org/Pages/FDAVideos.htm / / SocialTag 
Revised_1QNational News 2005.ind.indd